Making Immunotherapy Work for More Cancer Patients at Roswell Park

Courtesy of Roswell Cancer Talk Blog Many people think immunotherapy is a recent treatment for cancer patients, but it actually dates back to 1891, when William Coley, a bone sarcoma surgeon at the first U.S. cancer hospital, injected streptococcal organisms into a patient with inoperable cancer. Dr.

Read more

A Collaboration on First Large Study of Immunotherapy in Black Cancer Patients

A new collaboration between two Western New York cancer research leaders will help oncologists learn whether Black and white cancer patients respond differently to a game-changing immunotherapy treatment, and seeks to improve the safety and effectiveness of these newer drugs in diverse populations. Funded by a two-year,

Read more

A Cancer Innovation Engine: 10 Roswell Park Research Advances to Look for in 2021

A Cancer Innovation Engine: 10 Roswell Park Research Advances to Look for in 2021 Teams across cancer center are leading efforts to tackle the most urgent priorities in oncology   Despite coronavirus, Roswell Park teams have advanced projects in 10 key areas From immunotherapy to e-cigarettes, look

Read more

Influential Immunotherapy Organization at Roswell Park

Elected by a body of fellow immunotherapy researchers from across the globe, Roswell Park Comprehensive Cancer Center Deputy Director Kunle Odunsi, MD, PhD, FRCOG, FACOG, has been named an At-Large Director for the Society for Immunotherapy of Cancer (SITC) Board of Directors. The nonprofit organization’s members voted

Read more

Roswell Park to Assess Immunotherapy in COVID Cancer Patients

Roswell Park to Assess Immunotherapy Combination in Cancer Patients With COVID-19 Combination of rintatolimod and interferon alfa first proposed by Dr. Pawel Kalinski as cancer treatment Rintatolimod and interferon alfa first combined in Roswell Park cancer studies New trial will be first to combine rintatolimod and interferon

Read more